Director-linked funds add 75K Zenas BioPharma (ZBIO) shares at $20 in offering

robot
Abstract generation in progress

Entities linked to Zenas BioPharma director Hongbo Lu purchased 75,000 shares of common stock at $20.00 each through an underwritten public offering, bringing their indirect holdings to 422,968 shares. This transaction, detailed in a Form 4 filing, reflects a significant insider buy within Zenas BioPharma (ZBIO). The reporting person disclaims beneficial ownership beyond any pecuniary interest.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin